Fonar Pre-Tax Profit Margin 2012-2025 | FONR
Fonar pre-tax profit margin from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Fonar Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $0.11B | $0.01B | 11.43% |
| 2025-06-30 | $0.10B | $0.01B | 12.50% |
| 2025-03-31 | $0.10B | $0.01B | 13.59% |
| 2024-12-31 | $0.10B | $0.01B | 13.73% |
| 2024-09-30 | $0.10B | $0.02B | 16.67% |
| 2024-06-30 | $0.10B | $0.02B | 18.45% |
| 2024-03-31 | $0.10B | $0.02B | 19.42% |
| 2023-12-31 | $0.10B | $0.02B | 20.59% |
| 2023-09-30 | $0.10B | $0.02B | 18.81% |
| 2023-06-30 | $0.10B | $0.02B | 16.33% |
| 2023-03-31 | $0.10B | $0.02B | 17.53% |
| 2022-12-31 | $0.10B | $0.02B | 18.56% |
| 2022-09-30 | $0.10B | $0.02B | 21.65% |
| 2022-06-30 | $0.10B | $0.02B | 24.49% |
| 2022-03-31 | $0.10B | $0.02B | 24.49% |
| 2021-12-31 | $0.10B | $0.02B | 22.92% |
| 2021-09-30 | $0.09B | $0.02B | 21.51% |
| 2021-06-30 | $0.09B | $0.02B | 18.89% |
| 2021-03-31 | $0.09B | $0.01B | 16.28% |
| 2020-12-31 | $0.09B | $0.01B | 15.29% |
| 2020-09-30 | $0.09B | $0.01B | 15.29% |
| 2020-06-30 | $0.09B | $0.02B | 17.44% |
| 2020-03-31 | $0.09B | $0.02B | 20.69% |
| 2019-12-31 | $0.09B | $0.02B | 25.00% |
| 2019-09-30 | $0.09B | $0.02B | 26.14% |
| 2019-06-30 | $0.09B | $0.02B | 26.44% |
| 2019-03-31 | $0.09B | $0.02B | 27.91% |
| 2018-12-31 | $0.08B | $0.02B | 25.00% |
| 2018-09-30 | $0.08B | $0.02B | 25.30% |
| 2018-06-30 | $0.08B | $0.02B | 24.69% |
| 2018-03-31 | $0.08B | $0.02B | 23.46% |
| 2017-12-31 | $0.08B | $0.02B | 26.25% |
| 2017-09-30 | $0.08B | $0.02B | 25.64% |
| 2017-06-30 | $0.08B | $0.02B | 25.64% |
| 2017-03-31 | $0.08B | $0.02B | 25.00% |
| 2016-12-31 | $0.08B | $0.02B | 22.67% |
| 2016-09-30 | $0.08B | $0.02B | 21.33% |
| 2016-06-30 | $0.07B | $0.02B | 20.27% |
| 2016-03-31 | $0.07B | $0.02B | 20.83% |
| 2015-12-31 | $0.07B | $0.01B | 20.00% |
| 2015-09-30 | $0.07B | $0.01B | 18.84% |
| 2015-06-30 | $0.07B | $0.01B | 17.39% |
| 2015-03-31 | $0.07B | $0.01B | 15.94% |
| 2014-12-31 | $0.07B | $0.01B | 14.49% |
| 2014-09-30 | $0.07B | $0.01B | 14.29% |
| 2014-06-30 | $0.07B | $0.01B | 15.94% |
| 2014-03-31 | $0.07B | $0.01B | 17.14% |
| 2013-12-31 | $0.07B | $0.01B | 18.46% |
| 2013-09-30 | $0.06B | $0.01B | 19.30% |
| 2013-06-30 | $0.05B | $0.01B | 18.00% |
| 2013-03-31 | $0.04B | $0.01B | 18.60% |
| 2012-12-31 | $0.04B | $0.01B | 19.51% |
| 2012-09-30 | $0.04B | $0.01B | 20.00% |
| 2012-06-30 | $0.04B | $0.01B | 20.00% |
| 2012-03-31 | $0.04B | $0.01B | 16.22% |
| 2011-12-31 | $0.04B | $0.01B | 13.89% |
| 2011-09-30 | $0.04B | $0.00B | 11.43% |
| 2011-06-30 | $0.03B | $0.00B | 5.88% |
| 2011-03-31 | $0.04B | $0.00B | 5.71% |
| 2010-12-31 | $0.03B | $0.00B | 2.94% |
| 2010-09-30 | $0.03B | $0.00B | -2.94% |
| 2010-06-30 | $0.03B | $0.00B | -9.38% |
| 2010-03-31 | $0.03B | $0.00B | -9.09% |
| 2009-12-31 | $0.04B | $0.00B | -5.56% |
| 2009-09-30 | $0.04B | 0 | 0.00% |
| 2009-06-30 | $0.04B | $0.00B | 5.13% |
| 2009-03-31 | $0.04B | $-0.01B | -13.51% |
| 2008-12-31 | $0.03B | $-0.01B | -26.47% |
| 2008-09-30 | $0.03B | $-0.01B | -41.18% |
| 2008-06-30 | $0.04B | $-0.01B | -38.89% |
| 2008-03-31 | $0.04B | $-0.02B | -43.24% |
| 2007-12-31 | $0.04B | $-0.02B | -47.37% |
| 2007-09-30 | $0.04B | $-0.02B | -54.29% |
| 2007-06-30 | $0.03B | $-0.03B | -73.53% |
| 2007-03-31 | $0.03B | $-0.03B | -83.33% |
| 2006-12-31 | $0.03B | $-0.03B | -96.43% |
| 2006-09-30 | $0.03B | $-0.03B | -87.10% |
| 2006-06-30 | $0.03B | $-0.03B | -87.88% |
| 2006-03-31 | $0.05B | $-0.02B | -37.74% |
| 2005-12-31 | $0.07B | $-0.01B | -18.31% |
| 2005-09-30 | $0.09B | $-0.01B | -7.87% |
| 2005-06-30 | $0.10B | $0.00B | 1.92% |
| 2005-03-31 | $0.10B | 0 | 0.00% |
| 2004-12-31 | $0.09B | $0.00B | -1.06% |
| 2004-09-30 | $0.08B | $-0.01B | -6.02% |
| 2004-06-30 | $0.07B | $-0.01B | -14.08% |
| 2004-03-31 | $0.06B | $-0.01B | -18.75% |
| 2003-12-31 | $0.06B | $-0.02B | -30.91% |
| 2003-09-30 | $0.05B | $-0.02B | -32.08% |
| 2003-06-30 | $0.05B | $-0.02B | -30.19% |
| 2003-03-31 | $0.05B | $-0.02B | -30.77% |
| 2002-12-31 | $0.05B | $-0.01B | -26.92% |
| 2002-09-30 | $0.05B | $-0.02B | -34.78% |
| 2002-06-30 | $0.04B | $-0.02B | -39.53% |
| 2002-03-31 | $0.04B | $-0.02B | -45.00% |
| 2001-12-31 | $0.04B | $-0.02B | -41.46% |
| 2001-09-30 | $0.04B | $-0.02B | -36.59% |
| 2001-06-30 | $0.04B | $-0.02B | -37.50% |
| 2001-03-31 | $0.04B | $-0.01B | -35.00% |
| 2000-12-31 | $0.04B | $0.00B | -2.56% |
| 2000-09-30 | $0.04B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.116B | $0.104B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.859B | 21.09 |
| EssilorLuxottica (ESLOY) | France | $145.490B | 0.00 |
| Stryker (SYK) | United States | $137.164B | 27.23 |
| Boston Scientific (BSX) | United States | $135.332B | 30.95 |
| Medtronic (MDT) | Ireland | $129.919B | 18.00 |
| Medline (MDLN) | United States | $60.378B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.195B | 0.00 |
| Agilent Technologies (A) | United States | $39.301B | 24.84 |
| GE HealthCare Technologies (GEHC) | United States | $37.303B | 17.84 |
| ResMed (RMD) | United States | $37.266B | 25.79 |
| Koninklijke Philips (PHG) | Netherlands | $28.637B | 18.70 |
| Terumo (TRUMY) | Japan | $20.358B | 22.92 |
| Insulet (PODD) | United States | $19.697B | 61.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.349B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.055B | 0.00 |
| Baxter (BAX) | United States | $10.317B | 8.33 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.233B | 29.60 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.455B | 13.57 |
| BillionToOne (BLLN) | United States | $4.145B | 0.00 |
| Envista Holdings (NVST) | United States | $4.014B | 23.03 |
| ICU Medical (ICUI) | United States | $3.914B | 24.85 |
| Haemonetics (HAE) | United States | $3.278B | 14.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.257B | 14.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.159B | 47.26 |
| QuidelOrtho (QDEL) | United States | $2.076B | 13.35 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $1.990B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.945B | 39.15 |
| Curaleaf Holdings (CURLF) | Canada | $1.764B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.687B | 16.85 |
| Green Thumb Industries (GTBIF) | United States | $1.649B | 72.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.442B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.422B | 20.59 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.390B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.251B | 371.14 |
| Capricor Therapeutics (CAPR) | United States | $1.105B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.064B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.890B | 10.06 |
| Valneva SE (VALN) | France | $0.886B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| CeriBell (CBLL) | United States | $0.842B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.602B | 16.32 |
| Verano Holdings (VRNO) | United States | $0.516B | 0.00 |
| Cerus (CERS) | United States | $0.503B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.431B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.337B | 0.00 |
| Evolus (EOLS) | United States | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 22.51 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 144.33 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.235B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.199B | 17.54 |
| Sanara MedTech (SMTI) | United States | $0.198B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.195B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.183B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.132B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.56 |
| Sharps Technology (STSS) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.23 |
| Nephros (NEPH) | United States | $0.050B | 35.85 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.27 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |